|
|
|
|
|
CUSIP No. 38942Q 202 |
|
SCHEDULE 13D |
|
Page
7
of 8 |
Reference is hereby made to the statements on Schedule 13D originally filed with the Securities and Exchange
Commission (the SEC) on March 30, 2023, as amended by Amendment No 1 filed with the SEC on November 22, 2023 and Amendment No 2 filed with the SEC on February 8, 2024 (collectively, the Schedule 13D), which is
incorporated by reference.
This Amendment No. 3 to the Schedule 13D filed, relating to the common stock, par value $0.0001 per share (the
Common Stock) of CalciMedica, Inc., a Delaware corporation (the Issuer) amends and supplements certain of the items set forth therein.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 is hereby amended supplemented by adding the following at the end of Item 3:
Open-Market Purchases
Since February 8,
2024, Mr. Roberts and Ms. Leheny have made purchases of Common Stock in open market transactions using their personal funds. Such transactions are described in greater detail in Item 5 below.
Underwritten Offering
On October 30, 2024,
the Issuer entered into an underwriting agreement with JonesTrading Institutional Services LLC, (the Underwriter), relating to the issuance and sale in a public offering of 2,720,000 shares of the Issuers Common Stock. The price to
the public in the offering was $3.75 per share. Mr. Roberts and Ms. Leheny purchased 53,333 shares of Common Stock and 20,000 shares of Common Stock, respectively, at the public offering price from the Underwriter. The offering closed on
November 1, 2024. Mr. Roberts and Ms. Leheny each used personal funds to acquire the securities.
Item 5. Interest in Securities
of the Issuer.
Item 5 is hereby amended and supplemented as follows:
Certain warrants held by the Reporting Persons, which were acquired in January 2024 and had an exercise price of $5.36 per share, expired in
July 2024, without being exercised.
The Reporting Persons effected the following transactions in the Common Stock on the dates indicated,
and such transactions are the only transactions in the Common Stock by the Reporting Persons in the sixty days preceding the filing of this Amendment, or since the last 13D filing, whichever is less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
|
Nature of
Transaction |
|
Date |
|
|
Number of Shares of Common Stock |
|
|
Price per Share |
|
Roberts |
|
Open Market Purchase |
|
|
4/1/2024 |
|
|
|
746 |
|
|
$ |
3.90 |
|
Roberts |
|
Open Market Purchase |
|
|
4/2/2024 |
|
|
|
3,254 |
|
|
$ |
3.90 |
|
Roberts |
|
Open Market Purchase |
|
|
6/27/2024 |
|
|
|
5,000 |
|
|
$ |
3.22 |
|
Roberts |
|
Open Market Purchase |
|
|
8/21/2024 |
|
|
|
5,000 |
|
|
$ |
4.04 |
|
Roberts |
|
Open Market Purchase |
|
|
8/23/2024 |
|
|
|
2,000 |
|
|
$ |
3.5785 |
|
Roberts |
|
Open Market Purchase |
|
|
8/23/2024 |
|
|
|
3,000 |
|
|
$ |
3.57 |
|
Leheny |
|
Open Market Purchase |
|
|
8/27/2024 |
|
|
|
1,000 |
|
|
$ |
4.20 - $4.27 |
|
Leheny |
|
Purchase in Underwritten Offering |
|
|
11/1/2024 |
|
|
|
20,000 |
|
|
$ |
3.75 |
|
Roberts |
|
Purchase in Underwritten Offering |
|
|
11/1/2024 |
|
|
|
53,333 |
|
|
$ |
3.75 |
|